Google+

Abcodia’s partnership for pancreatic cancer biomarker discovery

I’m delighted to learn of Abcodia’s latest partnership with BIOUNIVERSA Srl, a spin-out from the University of Salerno, which aims to advance the development of the BAG3 protein biomarker for use in the early detection of pancreatic cancer. BIOUNIVERSA has strong scientific evidence that suggests that serum BAG3 is elevated in patients with pancreatic cancer at the time of clinical...
read more


Google+